|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Surgery, Toneyama National Hospital, Toyonaka, Osaka, Japan.
Correspondence to: Noriyoshi Sawabata, MD, FCCP, Division of Surgery, Toneyama National Hospital, 51-1 Toneyama, Toyonaka, Osaka, Japan 560-8552; e-mail: nori{at}toneyama.hosp.net.go.jp
| Abstract |
|---|
|
|
|---|
Objective: The authors assessed malignant cell spread through the needle tract following FNAC for peripheral lung carcinoma.
Materials and methods: Lung lobes resected from 20 patients during the treatment of lung carcinoma were examined. The visceral pleura over the lung carcinoma was irrigated by heparinized saline solution to clean the surface, and then irrigated before FNAC and irrigated following FNAC to collect cells on the visceral pleura. FNAC was performed once for each tumor. Papanicolaus method was employed for cytologic examination.
Results: There were 15 specimens of adenocarcinoma, 4 specimens of squamous cell carcinoma, and 1 specimen of atypical carcinoid. The maximum diameter of the specimens ranged from 10 to 60 mm (median, 25 mm). Pleural indentation was observed in 15 samples. All results of FNAC were positive and matched the histologic diagnosis. Pre-FNAC specimens revealed a positive malignancy rate of 10% (2 of 20), but post-FNAC specimens had a rate of 60% (12 of 20; p = 0.002)
Conclusion: FNAC has the potential to spread malignant cells to the pleural space. Further study is needed to determine the clinical significance of the spread of malignant cells in the pleural space.
Key Words: lung cancer fine-neddle aspiration cytologic technique malignant cell pleural space
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
FNAC was achieved with a 22-gauge needle and performed once for each tumor. The visceral pleura was washed by heparinized saline solution to clean cells on the surface (clearance), and then irrigated before FNAC and irrigated following FNAC to collect cells on the visceral pleura, employing the modified jet stream technique described by Ichinose and coworkers.9 In brief, the surface over the peripheral tumor was irrigated by a stream of heparinized saline solution employing a 20-mL syringe with a 22-gauge needle. The needle was passed only once through the visceral pleura. The method of collecting cells on the visceral pleura is schematically shown in Figure 1 . Two cups of 20-mL saline solution containing cells collected from the visceral surface were spun at 1,000 revolutions/min for 10 min. Then, the sediment obtained containing samples of FNAC was stained by Papanicolaus method and examined by a cytopathologist for malignancy. The cytopathologist was half blinded: he knew the hypothesis and the patients, but did not know if the fluids given to him were pre-FNAC type or post-FNAC type. We defined positive as "more than four malignant cells observable in a glass slide" for squamous cell carcinoma and atypical carcinoid, and as "clustered malignant cells observable in a glass slide" for adenocarcinoma.
|
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
It is very difficult to prove that pleural carcinomatosis has been caused by contaminated malignant cells in the pleural space after tumor excision or FNAC, because pleural carcinomatosis is able to occur even in patients with lung cancer diagnosed using a transbronchial procedure, which has little potential to spread malignant cells in the pleural space. It is also unknown whether disseminated malignant cells mature into tumor masses.
The incidence of clinically evidenced malignant implantation and growth along the biopsy tract or violated space has not been estimated. It is generally believed that most lung cancer cells have a low potential to grow in the pleural space. However, malignant tumors such as poorly differentiated carcinoma, small cell carcinoma, large cell carcinoma, and atypical carcinoid may have potential to grow, leading to pleural carcinomatosis. The next step in this research process will be to establish more concretely risk factors related to the malignant types of tumor.
Pleural carcinosis also has been reported after excision of malignant lung tumors diagnosed using video-assisted thoracic surgery.15 16 Negative malignancy at the surgical margin is necessary in order to prevent recurrence in the pleura.12 However, Sawabata and colleagues17 demonstrated that among samples showing a safe marginal distance (> 1 cm), 40% had cytologically positive margins. Our current experiment demonstrates positive malignant cells in 60% of pleura-irrigated specimens after FNAC, compared to 10% positive malignancy before FNAC. Even though this is not an in vivo examination, the same way of contamination through the needle hole in the pleura may occur during the clinical procedure. Both tumor excision and FNAC have the potential to spread malignant cells into the pleural space.
Lung cancer has to be diagnosed as early as possible in order to maximize the chance of recovery. Therefore, patients who might have lung cancer should undergo FNAC or excision or both when other examinations such as bronchoscopy or sputum cytology have failed to diagnose a lesion. Between FNAC and tumor excision, inasmuch as FNAC is less traumatic than tumor excision, FNAC is preferable despite the higher potential of malignant cell spread.
In conclusion, we demonstrated a 60% frequency of malignant cell spread from tumors through the needle tract. Thus far, it is not clear if disseminated malignant cells mature into tumor masses. Further study is needed to determine the clinical significance of the spread of malignant cells in the pleural space.
| Acknowledgements |
|---|
| Footnotes |
|---|
Received for publication August 20, 1999. Accepted for publication May 23, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Eberhardt, D. Anantham, F. Herth, D. Feller-Kopman, and A. Ernst Electromagnetic Navigation Diagnostic Bronchoscopy in Peripheral Lung Lesions Chest, June 1, 2007; 131(6): 1800 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Wisnivesky, C. I. Henschke, and D. F. Yankelevitz Diagnostic Percutaneous Transthoracic Needle Biopsy Does Not Affect Survival in Stage I Lung Cancer Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 684 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Schwarz, J. Greif, H. D. Becker, A. Ernst, and A. Mehta Real-Time Electromagnetic Navigation Bronchoscopy to Peripheral Lung Lesions Using Overlaid CT Images: The First Human Study. Chest, April 1, 2006; 129(4): 988 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, S. Yokota, H. Maeda, M. Nakagawa, T. Yamaguchi, T. Okada, and M. Itho Diagnosis of solitary pulmonary nodule: optimal strategy based on nodal size Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 105 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuguma, R. Nakahara, T. Kondo, Y. Kamiyama, K. Mori, and K. Yokoi Risk of Pleural Recurrence After Needle Biopsy in Patients With Resected Early Stage Lung Cancer Ann. Thorac. Surg., December 1, 2005; 80(6): 2026 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikuchi, K. Yamazaki, N. Sukoh, J. Kikuchi, H. Asahina, M. Imura, Y. Onodera, N. Kurimoto, I. Kinoshita, and M. Nishimura Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions Eur. Respir. J., October 1, 2004; 24(4): 533 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shinagawa, K. Yamazaki, Y. Onodera, K. Miyasaka, E. Kikuchi, H. Dosaka-Akita, and M. Nishimura CT-Guided Transbronchial Biopsy Using an Ultrathin Bronchoscope With Virtual Bronchoscopic Navigation Chest, March 1, 2004; 125(3): 1138 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Funakoshi, N. Sawabata, S.-i. Takeda, Y. Okumura, M. Hayakawa, and H. Maeda Bronchoscopically undiagnosed small peripheral lung tumors Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 517 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, Y. T. Kim, H. K. Lim, Y. H. Kim, and S. W. Sung Management for chest wall implantation of non-small cell lung cancer after fine-needle aspiration biopsy Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 828 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, A. Matsumura, M. Ohota, H. Maeda, H. Hirano, K. Nakagawa, and H. Matsuda Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Ann. Thorac. Surg., December 1, 2002; 74(6): 1953 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata Reply Ann. Thorac. Surg., November 1, 2002; 74(5): 1750 - 1750. [Full Text] [PDF] |
||||
![]() |
J. M. Reich Improved Survival and Higher Mortality* : The Conundrum of Lung Cancer Screening Chest, July 1, 2002; 122(1): 329 - 337. [Full Text] [PDF] |
||||
![]() |
N. Sawabata, H. Maeda, M. Ohta, and M. Hayakawa Operable Non-small Cell Lung Cancer Diagnosed by Transpleural Techniques : Do They Affect Relapse and Prognosis? Chest, November 1, 2001; 120(5): 1595 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kara, G. Alver, S. Dizbay Sak, and S. Kavukcu Implantation metastasis caused by fine needle aspiration biopsy following curative resection of stage IB non-small cell lung cancer Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 868 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ali Bedirhan, A. Turna, and N. Sawabata Fine-Needle Aspiration and Tumor Seeding Chest, September 1, 2001; 120(3): 1037 - 1038. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |